Cargando…
A PCOS Paradox: Does Inositol Therapy Find a Rationale in All the Different Phenotypes?
A recent evaluation of the published data regarding the PCOS topic has highlighted a paradox in the definition of this condition. Even though the name of the syndrome refers to ovarian dysfunction, it seems that patients diagnosed with PCOS are more likely affected by an endocrine and metabolic issu...
Autores principales: | Unfer, Vittorio, Dinicola, Simona, Russo, Michele |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10094056/ https://www.ncbi.nlm.nih.gov/pubmed/37047186 http://dx.doi.org/10.3390/ijms24076213 |
Ejemplares similares
-
Treatment with Myo-Inositol Does Not Improve the Clinical Features in All PCOS Phenotypes
por: Unfer, Vittorio, et al.
Publicado: (2023) -
Altered Ovarian Inositol Ratios May Account for Pathological Steroidogenesis in PCOS
por: Unfer, Vittorio, et al.
Publicado: (2020) -
Comparing the Efficacy of Myo-Inositol Plus α-Lactalbumin vs. Myo-Inositol Alone on Reproductive and Metabolic Disturbances of Polycystic Ovary Syndrome
por: Kamenov, Zdravko, et al.
Publicado: (2023) -
The Role of Inositols in the Hyperandrogenic Phenotypes of PCOS: A Re-Reading of Larner’s Results
por: Fedeli, Valeria, et al.
Publicado: (2023) -
Effects of myo-inositol plus alpha-lactalbumin in myo-inositol-resistant PCOS women
por: Montanino Oliva, Mario, et al.
Publicado: (2018)